Parkin Deficient Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Parkin (PARK2) deficiency causes autosomal recessive juvenile Parkinson's disease (AR-JP). Parkin is an E3 ubiquitin ligase essential for mitophagy, and its loss leads to accumulation of damaged mitochondria and progressive dopaminergic neuron degeneration.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
- E3 ubiquitin ligase that tags damaged mitochondria
- Mediates ubiquitination of mitochondrial proteins
- Recruits autophagy receptors (p62, OPTN, NDP52)
- Forms parkin bodies at mitochondrial clusters
- Failure to ubiquitinate damaged mitochondria
- Impaired mitophagy initiation
- Accumulation of dysfunctional mitochondria
- Failed mitochondrial turnover
- Enlarged and swollen mitochondria
- Reduced cristae density
- Decreased respiratory chain activity
- Increased mitochondrial DNA deletions
- Progressive loss of dopaminergic neurons
- Reduced dopamine transporter (DAT) activity
- Increased α-synuclein aggregation
- Lewy body formation
- Symptoms begin before age 20
- Initial gait disturbance
- Rapid progression
- Excellent levodopa response initially
- Early loss of substantia nigra pars compacta
- Relative preservation of other brain regions
- Less cortical involvement than sporadic PD
- PARK2 knockout mice
- Drosophila parkin mutants
- Patient-derived iPSC neurons
- CRISPR-edited parkin deletion lines
- Loss of TH-positive neurons
- Increased apoptosis markers
- Mitochondrial dysfunction indicators
- Autophagic flux impairment
- AAV-PARK2 delivery
- CRISPR-mediated correction
- Parkin protein replacement
- Mitophagy-inducing compounds
- Mitochondrial protective agents
- Ubiquitination pathway modulators
The study of Parkin Deficient Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kitada et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism (1998)
- Youle & Narendra, Mechanisms of mitophagy (2011)
- Pickrell & Youle, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015)
- Narendra et al., Parkin is recruited selectively to impaired mitochondria (2008)